Skip to content

Effect of Antidepressants on Back Pain

Efficacy of Antidepressants in Chronic Back Pain

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00018200
Enrollment
130
Registered
2001-07-05
Start date
1999-04-30
Completion date
2004-03-31
Last updated
2012-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain, Sciatica

Keywords

analgesia, Back pain, sciatica

Brief summary

The purpose of this study is to determine whether different types of antidepressant medicines relieve back pain that has lasted at least six months on a daily basis. Study participants will be assigned to treatment with either a antidepressant acting on the serotonin system in the brain (fluoxetine), one acting on the noradrenaline system (desipramine, or to a control medication not expected to relieve pain (benztropine). Each participant will be seen at least nine times during their 12 weeks on medication. This is a phase 2/3, outpatient study.

Interventions

DRUGDesipramine

Low exposure (40-70 ng/mL), Middle exposure (70-130 ng/mL), High exposure (130-200 ng/mL)

DRUGFluoxetine

Low exposure (200-399 ng/mL), Middle exposure (400-499 ng/mL), High exposure (500-700ng/mL)

Daily dose 0.125 to 0.5mg

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Chronic back pain (pain on a daily basis for six months or longer) * Age 18-65 * No major medical illness

Exclusion criteria

* medical contraindication to tricyclic antidepressants * recent alcohol or substance use disorder * bipolar disorder

Design outcomes

Primary

MeasureTime frame
Descriptor Differential Scale Pain Intensity12 weeks post baseline

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026